Growth Metrics

RemSleep Holdings (RMSL) Short-Term Debt issuances (2013 - 2017)

RemSleep Holdings recorded quarterly Short-Term Debt issuances of $19654.0 in Q3 2017, down 49.64% quarter-over-quarter from $39027.0 in Q2 2017.

RemSleep Holdings' Short-Term Debt issuances history runs 3 years deep, the most recent figure standing at $19654.0 for Q3 2017.

  • In Q3 2017, Short-Term Debt issuances changed N/A year-over-year to $19654.0; the TTM figure through Mar 2018 stood at $78115.0 (up 302.88% YoY), while the FY2014 annual figure was -$48.0, down 200.0% from the prior year.
  • Short-Term Debt issuances came in at $19654.0 for Q3 2017 at RemSleep Holdings, down from $39027.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $39027.0 in Q2 2017 to a low of -$45.0 in Q3 2014.
  • A 3-year average of $11157.6 and a median of $36.0 in 2013 frame the typical range for Short-Term Debt issuances.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 31.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -1.23 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 37.80 Mn
10 RemSleep Holdings - - -7,636.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2017 19,654.00
Sep 30, 2017 19,654.00
Jun 30, 2017 39,027.00
Jun 30, 2017 39,027.00
Mar 31, 2017 19,434.00
Mar 31, 2017 19,434.00
Sep 30, 2014 -45.00
Sep 30, 2014 -45.00
Jun 30, 2014 2.00
Jun 30, 2014 2.00
Mar 31, 2014 -5.00
Mar 31, 2014 -5.00
Dec 31, 2013 36.00
Dec 31, 2013 36.00